A 100% effective cancer vaccine? Russia’s Enteromix achieves success in trials; Here’s the full report you need to read
4 views
Skip to first unread message
rael-science
Oct 19, 2025, 1:34:42 PMOct 19
to rael science
The Raelian Movement
for those who are not afraid of the future : http://www.rael.org
Get Rael-Science on Facebook: http://www.facebook.com/raelscience
Get Rael-Science on Twitter: https://twitter.com/rael_science
A 100% effective cancer vaccine? Russia’s Enteromix achieves success in trials; Here’s the full report you need to read
SECTIONS
A
100% effective cancer vaccine? Russia’s Enteromix
achieves success in trials; Here’s the full report
you need to read
Synopsis
Russia's Enteromix vaccine has demonstrated 100% efficacy in preclinical trials, showing promise in fighting tumors. The vaccine, initially targeting colorectal cancer, has shown significant tumor reduction and improved survival rates. Researchers are also developing versions for glioblastoma and melanoma, potentially revolutionizing cancer treatment.
A vaccine
that could change the way we fight cancer is making
headlines. Russia’s Enteromix has reportedly achieved
100% efficacy in preclinical trials, showing both
safety and strong tumour-fighting abilities, according
to a report by Tass.
Veronika Skvortsova, head of the Federal Medical and Biological Agency (FMBA), revealed the results at the Eastern Economic Forum (EEF).
“The research spanned several years, with the last three dedicated to mandatory preclinical studies. The vaccine is now ready for use; we are awaiting official approval,” Tass quoted her as saying.
Skvortsova stressed that repeated administration of the vaccine remained safe, while also showing impressive results. Tumour growth slowed by 60–80%, survival rates improved, and significant reductions in tumour size were observed.
First target: colorectal cancer
The vaccine’s initial focus will be on colorectal
cancer, a leading cause of cancer-related deaths
worldwide. But the research does not stop there.
Scientists are also developing versions for
glioblastoma, a highly aggressive brain tumour, and
specific types of melanoma, including ocular melanoma,
all of which are at advanced stages of study.
Most of us associate vaccines with childhood diseases such as measles or chickenpox. These train the immune system to recognise dangerous germs. Cancer vaccines work on a similar principle, but instead of viruses, they help the body spot and attack cancer cells.
According to the American Cancer Society, some cancer
vaccines already exist for bladder and prostate
cancers, while the HPV vaccine prevents several types
of cancer before they begin. Enteromix, however,
belongs to a growing line of therapeutic vaccines
designed to treat cancer directly, making the body’s
natural defences more powerful.
Global stage for a breakthrough
The announcement came during the 10th Eastern Economic
Forum in Vladivostok (3–6 September), where over 8,400
delegates from 75 countries gathered under the theme
“The Far East: Cooperation for Peace and Prosperity.”
More than 100 thematic sessions were held, but it was
Enteromix that stole the spotlight.
If approved, this Russian vaccine could be a milestone in the fight against one of the world’s deadliest diseases, potentially reshaping cancer treatment as we know it.
Veronika Skvortsova, head of the Federal Medical and Biological Agency (FMBA), revealed the results at the Eastern Economic Forum (EEF).
“The research spanned several years, with the last three dedicated to mandatory preclinical studies. The vaccine is now ready for use; we are awaiting official approval,” Tass quoted her as saying.
Skvortsova stressed that repeated administration of the vaccine remained safe, while also showing impressive results. Tumour growth slowed by 60–80%, survival rates improved, and significant reductions in tumour size were observed.
First target: colorectal cancer
The vaccine’s initial focus will be on colorectal
cancer, a leading cause of cancer-related deaths
worldwide. But the research does not stop there.
Scientists are also developing versions for
glioblastoma, a highly aggressive brain tumour, and
specific types of melanoma, including ocular melanoma,
all of which are at advanced stages of study.Most of us associate vaccines with childhood diseases such as measles or chickenpox. These train the immune system to recognise dangerous germs. Cancer vaccines work on a similar principle, but instead of viruses, they help the body spot and attack cancer cells.
Global stage for a breakthrough
The announcement came during the 10th Eastern Economic
Forum in Vladivostok (3–6 September), where over 8,400
delegates from 75 countries gathered under the theme
“The Far East: Cooperation for Peace and Prosperity.”
More than 100 thematic sessions were held, but it was
Enteromix that stole the spotlight.If approved, this Russian vaccine could be a milestone in the fight against one of the world’s deadliest diseases, potentially reshaping cancer treatment as we know it.
Reply all
Reply to author
Forward
0 new messages